November 18, 2014 – Modulated Imaging learned today that the United States Patent and Trademark Office has issued US Patent 8,892,192 covering important updates to the understanding and implementation of Spatial Frequency Domain Imaging (SFDI). This patent covers advances in the technology which maximize the signal to noise ratio, allowing the technique to be more accurately and efficiently performed under a larger variety of lighting conditions.
SFDI is a next-generation tissue imaging technology that uses visible and near-infrared light to measure blood, oxygen, melanin, and other chromophores, while also visualizing many sub-dermal structures. Unlike many other imaging systems that use potentially harmful radiation or strong magnetic fields, SFDI uses only safe light waves. This is the fifth patent awarded which covers SFDI technology.
Modulated Imaging was founded to commercialize this breakthrough SFDI technology, and was spun out of the Photonic Incubator within the Beckman Laser Institute at UC Irvine. Since its inception, Modulated Imaging has been backed by a passionate team who believes in the potential of SFDI as a revolutionary tissue imaging technology for research in many fields, medical diagnostics, and therapy monitoring.